3PBIOVIAN News and Resources

3PBIOVIAN, a pan-European biologics CDMO, has recently partnered with Rokote Laboratories, a vaccine development company, to produce GMP batches of their adenovirus vector-based COVID-19 vaccine, FINCoVac 2.1. This vaccine is designed to induce a strong mucosal immune response in the nasopharyngeal